8 Coupons
-
Special Offer
-
30% off
sign out
.-
.
- fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. . .
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before.
.
.
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict .